Mark Pruzanski

Longtime Intercept CEO Mark Pruzanski departs as ailing NASH company tries to find its future
Endpoints
Thu, 12/10/20 - 11:19 am
Mark Pruzanski
Pharma CEOs
Intercept Pharma
NASH